Topic: Novartis AG

LONDON (Reuters) - Patients with high blood pressure treated with a combination of a Novartis hypertension drug and a generic medicine do better than if they take only one of the drugs alone, trial data released on Thursday showed.The results of a ...

Would you like to save money on Diovan the next time you fill a prescription for this high blood pressure medication? This Diovan coupons page will make it easier for you to save money on your prescription medications for the treatment of ...

Do you take Lotrel to treat high blood pressure? This Lotrel coupons page will make it easier for you to save money on your prescription medications for hypertension. Lotrel is the name brand for the generic drug name amlodipine and benazepril and ...

The US Food and Drug Administration (FDA) approved Tekamlo (aliskiren and amlodipine) tablets, a single-pill for the treatment of high blood pressure combining the only approved direct renin inhibitor, Tekturna (aliskiren), with the widely used calcium channel blocker amlodipine. "We welcome the ...

According to SFDA Southern Medicine Economic Institute Co., Ltd., Guangzhou Pharmaceutical Medicine punctuation retail market monitoring data, in August 2008, Kunming, Ningbo, two cities antihypertensive market size has grown. Antihypertensive drugs in recent years, the size of the retail market was a ...

According to SFDA Southern Medicine Economic Institute Co., Ltd., Guangzhou Pharmaceutical Medicine punctuation retail market monitoring data, in August 2008, Kunming, Ningbo, two cities antihypertensive market size has grown. Antihypertensive drugs in recent years, the size of the retail market was a ...

Results from 3A Registry demonstrate significant systolic blood pressure lowering with Rasilez after one year. ? After one year of treatment, Rasilez - the only approved direct renin inhibitor (DRI) - provided better systolic blood pressure control than other treatment regimens1. Results ...

Novartis says EU has approved best-selling hypertension drug Diovan for childrenPharmaceutical maker Novartis AG said Friday the European Union has approved its best-selling hypertension drug Diovan for treatment of children aged 6-18.The Basel, Switzerland-based company says national authorities now have to approve ...

ROYAL A Swiss pharmaceutical company is financing a Michigan study of the effectiveness of drug combinations in treating high blood pressure among diabetics. Basel, Switzerland-based Novartis AG is giving $440,000 for the research at Beaumont Hospitals in Royal Oak.

Updated European Society of Hypertension (ESH) guidelines recognize that Rasilez? monotherapy is effective at lowering blood pressure in a single daily dose1. The updated European Guidelines on Hypertension Management, appraised by an ESH task force, recognize that Rasilez effectively lowers high blood ...